abstract |
The present invention relates to a nutraceutical composition comprising at least a bacterial strain of the genus Bifidobacterium, at least a bacterial strain of the genus Lactobacillus, at least a prebiotic, and a transferrin selected from the group consisting of lactoferrin, ovotransferrin, and mixtures thereof, for use in the treatment of chemotherapy-related diseases. |